Yahoo Finance • 21 days ago
As the saying goes, there are many possible reasons for an insider to sell a stock, but only one reason to buy -- they expect to make money. So let's look at two noteworthy recent insider buys. On Monday, Nike's Director, Timothy D. Cook... Full story
Yahoo Finance • 29 days ago
Riverwater Partners, an investment management company, released its “Small Cap Strategy” Q3 2025 investor letter. A copy of the letter can be downloaded here. The Small Cap Core Strategy reported solid results for the quarter but did not k... Full story
Yahoo Finance • last month
The following companies are expected to report earnings after hours on 12/01/2025. Visit our Earnings Calendar for a full list of expected earnings releases. Credo Technology Group Holding Ltd (CRDO)is reporting for the quarter ending... Full story
Yahoo Finance • 2 months ago
MIAMI, Nov. 05, 2025 (GLOBE NEWSWIRE) -- The law firm of Shamis & Gentile, P.A. is investigating whether certain directors and officers of Vestis Corporation (NYSE: VSTS) breached their fiduciary duties owed to the company. If you are a... Full story
Yahoo Finance • 3 months ago
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Vestis (VSTS) To Contact Him Directly To Discuss Their Options If you are a long-term stockholder in Vestis between May 2, 2024, to... Full story
Yahoo Finance • 3 months ago
PHILADELPHIA, Oct. 09, 2025 (GLOBE NEWSWIRE) -- Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) – Class Action Survives Motion to Dismiss: Grabar Law Office is investigating claims on behalf of shareholders of Amylyx Pharmaceuticals, Inc.... Full story
Yahoo Finance • 3 months ago
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Vestis (VSTS) To Contact Him Directly To Discuss Their Options If you are a long-term stockholder in Vestis between May 2, 2024, to... Full story
Yahoo Finance • 3 months ago
PHILADELPHIA, Oct. 08, 2025 (GLOBE NEWSWIRE) -- Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX): Grabar Law Office is investigating claims on behalf of shareholders of Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) as securities fraud class a... Full story
Yahoo Finance • 3 months ago
PHILADELPHIA, Oct. 07, 2025 (GLOBE NEWSWIRE) -- Humana Inc. (NYSE: HUM): Grabar Law Office is investigating claims on behalf of shareholders of Humana Inc. (NYSE: HUM). The investigation concerns whether certain officers and directors... Full story
Yahoo Finance • 3 months ago
PHILADELPHIA, Oct. 06, 2025 (GLOBE NEWSWIRE) -- Fluor Corporation (NYSE: FLR): Grabar Law Office is investigating claims on behalf of shareholders of Fluor Corporation (NYSE: FLR). The investigation concerns whether certain officers an... Full story
Yahoo Finance • 3 months ago
PHILADELPHIA, Oct. 04, 2025 (GLOBE NEWSWIRE) -- Elevance Health Inc. (NYSE: ELV): Grabar Law Office is investigating claims on behalf of shareholders of Elevance Health Inc. (NYSE: ELV). The investigation concerns whether certain offic... Full story
Yahoo Finance • 4 months ago
SAN DIEGO, Sept. 12, 2025 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, PLLP is investigating potential violations of federal and state securities laws by certain officers and directors of the following companies: Telep... Full story
Yahoo Finance • 4 months ago
Riverwater Partners, an investment management company, released its “Small Cap Strategy” Q2 2025 investor letter. A copy of the letter can be downloaded here. The Small Cap Core Strategy underperformed the Russell 2000 in Q2 2025, primaril... Full story
Yahoo Finance • 5 months ago
Vestis Corp (NYSE:VSTS) disclosed Monday that its Compensation and Human Resources Committee has approved special, one-time long-term incentive awards for selected executive officers and key employees. The move comes as the company’s stock... Full story
Yahoo Finance • 5 months ago
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Vestis (VSTS) To Contact Him Directly To Discuss Their Options If you are a long-term stockholder in Vestis between May 2, 2024, to... Full story
Yahoo Finance • 5 months ago
NEW YORK, Aug. 09, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Vestis Corporation (“Vestis” or the “Company”) (NYSE: VSTS). Such investors are advised to contact Danielle Peyton at... Full story
Yahoo Finance • 5 months ago
NEW YORK, Aug. 08, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Vestis Corporation ("Vestis" or the "Company") (NYSE: VSTS) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover los... Full story
Yahoo Finance • 5 months ago
NEW YORK, Aug. 08, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Vestis Corporation (NYSE: VSTS) between May 2, 2024 and May 6, 2025, both dates inclusive (the “Clas... Full story
Yahoo Finance • 5 months ago
Bragar Eagel & Squire, P.C. Litigation Attorney Brandon Walker Encourages Investors Who Suffered Losses In Vestis (VSTS) To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Vestis between May 2, 202... Full story
Yahoo Finance • 5 months ago
NEW YORK, Aug. 07, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Vestis Corporation (NYSE: VSTS). Shareholders who purchased shares of VSTS during the class period listed are encouraged to co... Full story